Literature DB >> 33026169

Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.

Saeed Alshahrani1, Abdullatif Khan2.   

Abstract

BACKGROUND: Lingual ASPS is extremely rare and aggressive tumor. rearrangement is typically detected in ASPS patients using FISH analysis. AIM: To present the clinical, histopathological, and radiological features of lingual Alveolar Soft Part Sarcoma.
METHOD: A 30-year-old male presented with a painless, slowly growing mass of the tongue. Initial impression was of benign vascular lesion. Later, the patient became symptomatic as the mass progressed in size, which necessitated further investigations. RESULT: A lip-split, mandibulotomy was performed for the excision of the tumor and revealed an alveolar soft part sarcoma with PAS-positive, diastase resistant intracytoplasmic granules. However, molecular analysis using FISH was negative for TFE3 rearrangement. Patient underwent partial glossectomy with postoperative radiotherapy.
CONCLUSION: Clinical and pathological correlation of ASPS is very useful to reach a proper diagnosis.
© 2020 The Authors. Cancer Reports published by Wiley Periodicals LLC.

Entities:  

Keywords:  glossectomy; lingual cancer; oral; sarcoma; tumor

Year:  2020        PMID: 33026169      PMCID: PMC7941505          DOI: 10.1002/cnr2.1298

Source DB:  PubMed          Journal:  Cancer Rep (Hoboken)        ISSN: 2573-8348


  13 in total

1.  Alveolar soft-part sarcomas; structurally characteristic tumors of uncertain histogenesis.

Authors:  W M CHRISTOPHERSON; F W FOOTE; F W STEWART
Journal:  Cancer       Date:  1952-01       Impact factor: 6.860

2.  [Alveolar soft part sarcoma in children: a clinicopathological study of 13 cases].

Authors:  L Y Wang; C Jia; M Zhang; H B An; N Zhang; L Wang; L B Fu; L J He
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2020-02-08

3.  Modeling Alveolar Soft Part Sarcoma Unveils Novel Mechanisms of Metastasis.

Authors:  Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Rikuka Shimizu; Yutaka Takazawa; Takuro Nakamura
Journal:  Cancer Res       Date:  2016-12-15       Impact factor: 12.701

4.  Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study.

Authors:  Rosalind F Sharain; Allen M Gown; Patricia T Greipp; Andrew L Folpe
Journal:  Hum Pathol       Date:  2019-03-06       Impact factor: 3.466

5.  RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.

Authors:  Pedram Argani; Lei Zhang; Victor E Reuter; Satish K Tickoo; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2017-05       Impact factor: 6.394

Review 6.  Oral alveolar soft part sarcoma in childhood and adolescence: report of two cases and review of literature.

Authors:  Prokopios P Argyris; Robyn C Reed; J Carlos Manivel; Dolores Lopez-Terrada; Jared Jakacky; Zuzan Cayci; Konstantinos I Tosios; Stefan E Pambuccian; Lester D R Thompson; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2012-09-08

Review 7.  Alveolar soft-part sarcoma: a review of the pathology and histogenesis.

Authors:  N G Ordóñez; B Mackay
Journal:  Ultrastruct Pathol       Date:  1998 Jul-Aug       Impact factor: 1.094

8.  Prominent Intracytoplasmic Crystals in Alveolar Soft Part Sarcoma (ASPS): An Aid in Cytological Diagnosis.

Authors:  Rahul Mannan; Tejinder Singh Bhasin; Parampreet Kaur; Mridu Manjari; Karamjit Singh Gill
Journal:  J Clin Diagn Res       Date:  2014-02-03

Review 9.  Alveolar soft-part sarcoma of the oral cavity: A review of literature.

Authors:  Pankaj Shelke; Gargi Sachin Sarode; Sachin Chakradhar Sarode; Rahul Anand; Ghevaram Prajapati; Shankargouda Patil
Journal:  Rare Tumors       Date:  2018-12-17

10.  Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.

Authors:  Saeed Alshahrani; Abdullatif Khan
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-07
View more
  1 in total

1.  Lingual alveolar soft part sarcoma with absent TFE3 rearrangement.

Authors:  Saeed Alshahrani; Abdullatif Khan
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.